With a trustbusting renaissance probably winding down, President Joe Biden’s team is trying to make the most of the era ...

VitalCaring Group – the home health and hospice company led by April Anthony – got caught in the crosshairs of the U.S. Department of Justice (DOJ) this ...

The market pulled back from its record high this week as traders reacted to some key economic data and earnings reports.

Here are five moves from payers that are making waves in the ASC space: ...

U.S. stocks drifted lower Tuesday as momentum cooled for the torrid “Trump trade” that swept Wall Street following Donald Trump’s presidential victory. Stocks had been broadly rising since last week ...

Juniper Networks (NYSE:JNPR) ticked lower by 1.2% amid some speculation about the Dept. of Justice's review of its planned ...

Truist Financial analyst David S Macdonald maintained a Hold rating on Amedisys (AMED – Research Report) today and set a price target of ...

Regeneron and Sanofi's Dupixent sBLA for treating chronic spontaneous urticaria in patients 12+ gets FDA review, with a ...

In other news, I'm hosting the Oscars," Conan O'Brien said. The Minnesota DFL Party is calling on the state's Republican ...

President-elect Donald Trump's choice for defense secretary in his second term, Pete Hegseth, was investigated for alleged ...

AstraZeneca and Amgen announced that a Phase 3 trial of Tezspire (tezepelumab) showed a statistically significant and ...